Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Effect of HIV and IL28B on NK control of HCV
Dendritic Cells For Prevention of Islet Graft Rejection
Postdoctoral Training Program in Caries Research
Biomedical Research Support
Development of a Sonic IR Research Instrument for Nondestructive Testing
Recently added grants:
Membrane-Mediated Interactions of the Bcl-xL/Bid/Bax Triad of Apoptotic Regulators
Pre- and Peri-natal Predictors of Childhood Obesity
From GWAS loci to blood pressure genes, variants & mechanisms
SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms.
A Nanopatterned Mea-Based Functional Phenotyping Assay for Drug-Induced Cardiotoxicity Screening
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07153-17-0-1
Application #
7574913
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Johns Hopkins University
$389,122
NIH 2007
N01 HL
Pediatric Hydroxyuera Phase III Clinical Trial
Casella, James F. /
$523,182
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant